Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
The recent publication of an article on trends in the prescription of finasteride has re-stimulated the debate on the use of 5α-reductase inhibitors (5-ARIs) like finasteride and dutasteride in the prevention of prostate cancer. … READ MORE …
Filed under: Management, Prevention | Tagged: 5-ARIs, dutasteride, finasteride, Prevention | 2 Comments »
In August this year, Vis and Schröder published the first of two summary reviews on the key targets of hormonal treatment of prostate cancer. The second of these two key reviews has now appeared in the November issue of BJU International. … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: 5-ARIs, 5α-reductase inhibitor | 11 Comments »
Reports today deal with:
Filed under: Drugs in development, Management, Prevention, Risk, Treatment, Uncategorized | Tagged: 5-ARIs, 5α-reductase inhibitors, chemo-immunotherapy, HIFU, high-intensity focuse ultrasound, osteoprotegerin, Prevention | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site